Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1016/j.annonc.2024.07.719

Type

Journal article

Publication Date

01/09/2024

Volume

35

Pages

827 - 828

Total pages

1

Addresses

Department of Immunology, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain. Electronic address: imelero@unav.es.

Keywords

Humans, Antineoplastic Agents, Immunological, Ipilimumab, Nivolumab